Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2010 Oct 12;17(3):330–340. doi: 10.1016/j.bbmt.2010.09.020

Table 5.

Statistical comparison between groups from Figure 5

Groups compared MST (days) and survival rate (%) P value
DL vs. MMB.319 25, 4% vs. 20.5, 0% = 0.013
GM-MMB3.19 pre-BMT + DL (s.c.) vs. MMB3.19 + DL 77, 50% vs. 25, 4% < 0.01
GM-MMB3.19 pre-BMT + DL (i.p.) vs. MMB3.19 + DL 85% vs. 25, 4% < 0.01
GM-MMB3.19 pre-BMT + DL (i.p.) vs. GM-MMB3.19 pre-BMT + DL (s.c.) 85% vs. 77, 50% = 0.04

Groups were compared using non-parametric Log-Rank test